Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-03-15 @ 11:18 PM
Study NCT ID:
NCT07007767
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-06
First Post:
2025-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies）
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UHCT-CRC-240601
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None